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Abstract
An important issue in critical care medicine is the identification of ways to protect the lungs from oxygen toxicity and
reduce systemic oxidative stress in conditions requiring mechanical ventilation and high levels of oxygen. One way to
prevent oxygen toxicity is to augment antioxidant enzyme activity in the respiratory system. The current study investigated
the ability of aerosolized extracellular superoxide dismutase (EC-SOD) to protect the lungs from hyperoxic injury.
Recombinant human EC-SOD (rhEC-SOD) was produced from a synthetic cassette constructed in the methylotrophic yeast
Pichia pastoris. Female CD-1 mice were exposed in hyperoxia (FiO2.95%) to induce lung injury. The therapeutic effects of
EC-SOD and copper-zinc SOD (CuZn-SOD) via an aerosol delivery system for lung injury and systemic oxidative stress at 24,
48, 72 and 96 h of hyperoxia were measured by bronchoalveolar lavage, wet/dry ratio, lung histology, and 8-oxo-29-
deoxyguanosine (8-oxo-dG) in lung and liver tissues. After exposure to hyperoxia, the wet/dry weight ratio remained stable
before day 2 but increased significantly after day 3. The levels of oxidative biomarker 8-oxo-dG in the lung and liver were
significantly decreased on day 2 (P,0.01) but the marker in the liver increased abruptly after day 3 of hyperoxia when the
mortality increased. Treatment with aerosolized rhEC-SOD increased the survival rate at day 3 under hyperoxia to 95.8%,
which was significantly higher than that of the control group (57.1%), albumin treated group (33.3%), and CuZn-SOD
treated group (75%). The protective effects of EC-SOD against hyperoxia were further confirmed by reduced lung edema
and systemic oxidative stress. Aerosolized EC-SOD protected mice against oxygen toxicity and reduced mortality in a
hyperoxic model. The results encourage the use of an aerosol therapy with EC-SOD in intensive care units to reduce
oxidative injury in patients with severe hypoxemic respiratory failure, including acute respiratory distress syndrome (ARDS).
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Introduction
Acute lung injury (ALI) and its severe form, acute respiratory
distress syndrome (ARDS), are common causes of morbidity and
mortality in intensive care units. ALI occurs as a result of direct
intra-alveolar injury or indirect injury following systemic inflam-
mation. ALI is characterized by refractory hypoxemia due to
widespread alveolar flooding after insult. Currently, the primary
management of ALI includes treatment for underlying diseases,
adequate hemodynamic support and mechanical ventilation with
lung-protective strategies [1]. To maintain adequate tissue
oxygenation, higher levels of supplemental oxygen are often
required.
In most mammalian species, exposure to hyperoxia can result in
lung injury and commonly produces pathological changes similar
to those seen in ARDS. Although similar findings have not been
reproduced in humans with healthy lungs, most clinicians suspect
that oxygen may exacerbate and even cause ALI in critically ill
patients [2]. A recent study revealed that even moderate hyperoxia
(FiO2=50%) exacerbates ventilator-induced lung injury (VILI) in a
rabbit model [3]. Clinical studies have supported the important role
that oxidative stress plays an in the pathogenesis of ALI and other
lung diseases, including pulmonary fibrosis, chronic obstructive
pulmonary disease, and bronchopulmonary dysplasia [4–6].
Oxygen toxicity is mediated by reactive oxygen species (ROS)
[7] including superoxide anion (O2
2), hydrogen peroxide (H2O2),
and hydroxyl radicals (?OH). ROS can cause lipid peroxidation,
oxidation of proteins and DNA damage, which can all induce
cellular dysfunction and even cell death [8]. To counteract ROS, a
complex network of antioxidants, including enzymatic and non-
enzymatic antioxidants, exists in biological systems. Enzymatic
antioxidants, which include superoxide dismutase (SOD), catalase,
and glutathione peroxidase, provide the first line of defense against
ROS.
Superoxide dismutases are a group of isoenzymes that function
as key antioxidants in the metabolism of oxygen free radicals.
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hydrogen peroxide, thereby maintaining a low concentration of
the toxic superoxide free radical. Superoxide dismutases are
metalloenzymes and exist in three different forms in mammals.
Copper-zinc SOD (CuZn-SOD or SOD1) is found in the
cytoplasma and nuclei of cells, manganese SOD (Mn-SOD or
SOD2) is found in the mitochondria, and Cu/Zn-containing
extracellular SOD (EC-SOD or SOD3) is predominantly found in
the extracellular matrix of tissues [8,9].
EC-SOD has been reported to be a multimeric glycoprotein
composed of at least four identical 30 kD subunits with het-
erogeneous affinity for heparin in extracellular matrix (ECM) and
cell surfaces [10]. EC-SOD activity has been reported to be
markedly increased in the lung compared with other vital organs,
such as the liver, kidney, heart, and brain [8]. EC-SOD has been
proposed to play an important role in reduction of extracellular
oxidative stress resulting from direct exposure of the lung to the
external environment [11]. A recent report using Cre-lox
technology revealed that an acute 50% reduction of EC-SOD
led to a five-fold increase in lung superoxide anions, acute lung
injury and 85% mortality within 7 days in the presence of room
air [12]. An overexpression of EC-SOD in the airway of
transgenic mice attenuates the acute inflammation and protects
the lung against hyperoxia [13]. An exposure to 100% oxygen
for 72 h can induce proteolysis and depletion of EC-SOD
and enhance oxidant/anti-oxidant imbalance in alveolar spaces
[14].
heterogeneousA rational strategy for prevention of oxygen
toxicity is the augmentation of antioxidant enzyme activity in the
respiratory system. Administration of recombinant human CuZn-
SOD and Mn-SOD by an aerosol delivery system has been found
to protect the lungs against hyperoxic injury [15,16]. Recombi-
nant human EC-SOD (rhEC-SOD) was expressed and purified in
both E. coli and the milk of rabbits [17,18], but no in vivo activity
studies have been performed. In this study, we produced rhEC-
SOD in Pichia pastoris, a methylotrophic yeast, and tested the
hypothesis that aerosolized rhEC-SOD could protect against
oxygen toxicity in a hyperoxic model. We also investigated
whether 8-oxo-dG was a useful biomarker for hyperoxic injury. In
doing so, we found that rhEC-SOD attenuated hyperoxic lung
injury, reduced systemic oxidative stress and increased survival in
hyperoxia.
Materials and Methods
Production of human EC-SOD in Pichia pastoris
The construction, screening, and production of human EC-
SOD have been described in detail elsewhere [9]. Briefly, the
hSOD3 cDNA fragment was amplified by PCR and cloned into
pPICZaA yeast expression vector (Figure 1A). After electropora-
tion-stimulated transformation into P. pastoris, selected the
pPICZaA-hSOD3-transformed colonies with high levels of
Zeocin. Recombinant hEC-SOD protein was produced and
secreted into the culture medium under the induction of methanol.
Three liters of culture medium were concentrated by stirred-cell
ultrafiltration (YM-10, Amicon, Danvers, MA). The precipitate
was resuspended in a 5 mM Tris buffer (pH 7.4) containing
50 mM NaCl and dialyzed against the same buffer. The desalted
fractions were separated and purified by a fast protein liquid
chromatography (FPLC) system (AKTA purifier 10, Amersham
Pharmacia Biotech., Arlington Heights, IL) [9]. The activity unit
of rhEC-SOD antioxidant was assayed with a water-soluble
tetrazolium salt (WST-1) kit (Dojindo Molecular Technologies,
Inc., Rockville, MD) as described [9].
Experimental animals
Six- to eight-week-old female CD-1 strain mice weighing 20–
30 g were purchased from BioLASCO Taiwan, INC. The mice
were housed in an SPF-grade animal facility under a 12-h light/
12-h dark cycle with a constant temperature (2561uC). Mice were
provided with food and water ad libitum throughout the
experiment. This study was conducted according to institutional
guidelines and approved by the Institutional Animal Care and
Utilization Committee of National Chung-Hsing University,
Taiwan (IACUC No. 96-52).
Oxygen exposure and aerosol delivery system
Mice were exposed to hyperoxic conditions (FiO2 .95%) in a
36620620-cm plexiglass chamber with a hole (2 cm in diameter)
to allow the continuous flow of 100% oxygen (1 L/min) and
aerosol into the chamber. Oxygen level was very stable (97–99%,
showed in Figure S1) when monitored every hour in light cycle of
housing with an oxygen analyzer (MiniOX I, MSA Canada, Inc.,
Canada). Two ultrasonic nebulizers (SUMO V15, Taiwan) were
used for the aerosolization of the study drugs, and they were
connected to the oxygen delivery system.
Experimental protocol
The first aim of the experiments was to demonstrate the time
course of lung injury and oxidative stress by examining the effects
of hyperoxic conditions at 24, 48, 72, and 96 h. At each time
point, six mice in each group were sacrificed for the following
studies including bronchoalveolar lavage, wet/dry ratio, lung
histology, and 8-oxo-dG determination in lung and liver tissues
(n=6 in each group). The second aim of the experiments was to
test the hypothesis that aerosolized EC-SOD and CuZn-SOD
could reduce systemic oxidative stress and lung injury after 96 h in
hyperoxic conditions. The mice were divided into three groups: 1)
SOD1 inhalation (10,000 units/day, bovine CuZn-SOD from
Sigma, USA), 2) SOD3 inhalation (10,000 units/day, rhEC-SOD
produced by this study), 3) albumin inhalation (890 mg/mL in
PBS, equal to the SOD3 concentration, as a non-SOD control),
and 4) PBS inhalation (as a control). At least six mice were
recruited in each group. SODs or albumin solved in PBS 70 mL
or PBS 70 mL alone was delivered by this aerosol system in 8 h
per day. About 36% of the weight of solutions was left in the
system 8 hours after aerosolization. The health of mice was
monitored daily throughout the experimental period. The survival
rate was also monitored daily, and at least six mice from each
group were sacrificed at 96 h for the experiments.
Bronchoalveolar lavage
The trachea was exposed with a midline incision and
cannulated with a modified 21-gauge needle. After preliminary
test, bronchoalveolar lavage (BAL) was performed four times with
2.5 mL PBS per time. At least 1 mL was recovered after each
lavage. The BAL fluid was mixed and centrifuged at 5006g for
10 min at 4uC. Cell pellets were resuspended in 1 mL PBS, and
cell counts were performed [16]. The supernatant was submitted
to total protein analysis using a bicinchoninic acid (BCA) protein
assay (Pierce, Rockford, IL).
Lung wet/dry weight ratio
After euthanasia of the mice, the lungs were surgically dissected
away from the heart, trachea, and main bronchi. Each lung was
blotted dry, weighed, and dried to a constant weight by placing the
lung specimen in an oven at 70uC for 48 h. The ratio of the wet
lung to the dry lung was calculated to assess lung edema.
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EC-SOD
After sacrificing the mice, the left lobes of the lung were
dissected and inflated with 0.6 mL of 10% formalin for histological
study. Paraffin sections prepared from the lungs were stained with
hematoxylin and eosin for evaluation. We assessed the degree of
alveolar congestion, hemorrhage, leukocyte infiltration, and the
thickness of the alveolar wall [19]. For immunohistochemical
(IHC) staining of EC-SOD, the lung tissue was fixed with
paraformaldehyde and embedded in O.C.T. compound (Tissue-
Tek
R; Sakura, Japan), then frozen and microdissected for IHC
analysis [20]. Briefly 5 mm section placed on slides were incubated
with rabbit anti-rhEC-SOD polycolonal first antibody (1:200
dilution; EMD Millipore, Billerica, MA) and biotin-labeled anti-
rabbit IgG antibody (1:2,000 dilution; Abcam, Cambridge, MA).
The Vectastain ABC kit (Vector Laboratories, Burlingame, CA)
was used for rhEC-SOD staining.
8-oxo-dG analysis of lung and liver tissues
Mice were sacrificed to get lung and liver tissues for quantitative
determination of 8-oxo-dG. Deoxyribonucleic acid extractions
were performed as previously described [21], and DNA digestions
were performed by following the Dig-1 protocol as described
previously [22]. Artificial oxidation was minimized by the NaI/2-
propanol method. Isotope-dilution liquid chromatography-tandem
mass spectrometry (LC-MS/MS) with on-line solid-phase extrac-
Figure 1. Production and secretion of rhEC-SOD in Pichia pastoris.A .Structure of the P. pastoris a-factor/human-EC-SOD secretion cassette.
The hSOD3 cDNA fragment was cloned into pPICZaA vector The AOX1 gene can easily be induced by methanol. B. Representative SDS-PAGE analysis
of time course of rhEC-SOD expression and secretion in the yeast cultures after methanol induction. C. Western blot analysis of secreted rhEC-SOD
with a mouse anti-human EC-SOD monoclonal antibody. The amount of rhEC-SOD was determined quantitatively by ELISA. Results are representative
of three experiments. D. The purification of rhEC-SOD by FPLC system. The purity and molecular weight of purified rhEC-SOD (fraction No. 10) was
checked by 12% SDS-PAGE.
doi:10.1371/journal.pone.0026870.g001
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After the addition of
15N-labeled 8-oxo-dG as an internal
standard, the samples were analyzed within 10 min.
Data analysis
All experimental results were expressed as mean 6 SE. The
Levene test was used to determine whether values were normally
distributed. After this assessment, either the Mann-Whitney U test
or the Student’s t test was applied (StatView, Abacus). Differences
with p,0.05 (*) or p,0.01 (**) were considered to be statistically
significant.
Results
Recombinant human EC-SOD expression and purification
To produce bioactive rhEC-SOD antioxidant, a synthetic
secretion cassette for human EC-SOD in yeast vector was
constructed and transformed into P. pastoris. Twenty-four hours
after induction, the amount of rhEC-SOD in the yeast culture was
significantly increased as shown in the SDS-PAGE (Figure 1B).
The secreted dimeric rhEC-SOD (70 kD) in the culture medium
was further assayed by western blot and ELISA (Figure 1C). After
purification with FPLC, the pure dimeric rhEC-SOD was
collected from fraction No. 10 (Figure 1D) with a specific activity
of 251.72 U/mg. A total activity of 10,000 units/mL of rhEC-
SOD was prepared for the experiments.
Effect of oxidative stress on lung injury and mortality
after hyperoxia
When CD-1 mice were exposed to hyperoxic conditions (FiO2
.95%), 100% of the mice died by day 5 (Figure 2A). The wet/dry
weight ratio, which was used as a marker of lung edema, remained
stable before day 2 but increased significantly after day 3 and day
4( P ,0.05) (Figure 2B). The levels of 8-oxo-dG (Figure 2C) in the
lungs decreased significantly at day 2 (P,0.01) and increased
gradually after day 3. Similarly, the level of 8-oxo-dG in liver
tissue, which has been proposed as a measure of systemic oxidative
stress, decreased before day 2 and increased at day 3 (P,0.05).
The abrupt elevation of 8-oxo-dG in the liver tissue on day 3 was
concurrent with the development of lung edema and a decline in
the survival curve.
Aerosolized rhEC-SOD increased survival from hyperoxia
The survival rate of the PBS inhalation group was 57.1% after
72 h of hyperoxia (Figure 3). Treatment with aerosolized rhEC-
SOD increased the survival rate to 95.8% at 72 h after hyperoxia
exposure, which was significantly higher than that in the control
(57.1%, P,0.01), albumin (33.3%, P,0.01), and CuZn-SOD
(75.0%, P,0.05) groups. Aerosolized CuZn-SOD seemed to
increase the survival, but the results were not significant compared
with the control group (P=0.098). Mice that survived beyond day
3 in the PBS group were clearly impaired and had limited
movement. In contrast, the mice in the rhEC-SOD group
demonstrated remarkable tolerance to hyperoxia (as shown in
the Video S1).
Aerosolized rhEC-SOD and CuZn-SOD reduced hyperoxic
lung edema
The wet/dry weight ratios of the lungs from the SOD-treated
groups (Figure 4A) were significantly lower than the ratios in the
PBS control group (P,0.01), but there was no significant
difference between the CuZn-SOD and rhEC-SOD groups. The
total cell count in the BAL fluid, a marker of lung injury, was also
significantly lower in the SOD-treated groups compared with the
PBS or albumin control group (P,0.01; Figure 4B). In addition,
the total cell count in the BAL fluid of the rhEC-SOD group was
even lower than that in the CuZn-SOD group (P,0.05).
Protective effect of rhEC-SOD against hyperoxic lung
injury was greater than the effect of CuZn-SOD
To further confirm the protective effect of rhEC-SOD,
histopathological examination of lungs was performed after 96 h
of hyperoxia. Pulmonary edema and alveolar infiltration of
neutrophils were evident in the PBS, albumin, and CuZn-SOD
groups (Figure 5). Mice from the group that received aerosolized
rhEC-SOD exhibited less neutrophil infiltration and lung edema
(Figure 5A and 5B). Immunohistochemical staining of EC-SOD
was performed to assess the efficiency of this aerosol system and
the distribution of EC-SOD in lung after aerosolization. In the
EC-SOD treatment group, EC-SOD was expressed diffusely in
lungs, including epithelium of airway, alveolar space, and even
interstitium (Figure 6B). Because of the cross reaction of the
polyclonal antibodies with endogenous EC-SOD, EC-SOD was
found in the epithelium of bronchi and bronchiole in the PBS
control group (Figure 6A).
Protective effect of rhEC-SOD against systemic oxidative
stress was greater than that of CuZn-SOD
To test the hypothesis that aerosolized rhEC-SOD reduced
systemic oxidative stress and increased survival following hyper-
oxia, we measured the levels of 8-oxo-dG in lung and liver tissues
after 72 h and 96 h in hyperoxic conditions. The levels of 8-oxo-
dG in the lung tissues at day 3 (Figure 7A) and day 4 (Figure 7B)
were reduced by treatment with aerosolized rhEC-SOD and
CuZn-SOD. The difference between the protective effects in the
rhEC-SOD (P,0.01) and CuZn-SOD (P,0.05) groups was
shown in the liver tissues, but did not reflect the equivalent
reduction of 8-oxo-dG in the lung tissues under 96 h hyperoxic
condition (Figure 7B).
Discussion
There were two new findings in this study. First, aerosolized
human EC-SOD administration in mice protected against acute
lung injury and systemic oxidative stress caused by hyperoxia
(FiO2.95%). Extracellular superoxide dismutase aerosol therapy
reduced the severity of lung injury, which was demonstrated by the
wet/dry weight ratio and histopathology, as well as the systemic
oxidative stress, which was demonstrated by 8-oxo-dG in the liver.
In addition, EC-SOD reduced the mortality rate. The protective
effect of rhEC-SOD against oxygen toxicity was greater than the
effect of bovine CuZn-SOD in this animal model. Second, we
found that 8-oxo-dG could be used as an oxidative biomarker in a
hyperoxic model. Systemic oxidative stress, demonstrated by 8-
oxo-dG in the nuclei of liver tissue, was concurrent with the
development of pulmonary edema, the decline in the survival
curve and the protective effects of aerosol SODs.
Numerous studies have shown that oxidants are important
mediators of ALI, and augmentation of antioxidant enzymes is
protective in animal models of ALI. SODs, especially EC-SOD,
have been found to play an important role in the pathogenesis of
ALI. EC-SOD knockout mice have exaggerated inflammation in
response to hyperoxia [24] and lipopolysaccharide (LPS) challenge
[25]. On the other side, an overexpression of EC-SOD in the
airway of transgenic mice attenuates ALI and protects the lung
against hyperoxia [13]. The role of EC-SOD was further
confirmed by the report that an acute reduction of EC-SOD in
Aerosolized EC-SOD Prevents Lung Injury
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26870Figure 2. Effects of oxidative stress on lung injury and survival in hyperoxia (FiO2 .95%). A. The survival of untreated mice after
exposure to hyperoxic conditions (n=24). B. Pulmonary edema was measured based on the wet/dry weight ratio of the lungs (n=6 in each group).
C. Time course of oxidative stress in lung and liver tissues after exposure to hyperoxic conditions (n=6 in each group). The oxidative marker 8-oxo-
dG was determined with LC-MS/MS with on-line SPE. Values are expressed as the amount of 8-oxo-dG per 10
6 dG.
doi:10.1371/journal.pone.0026870.g002
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same report, intraperitoneal injection of the SOD mimetic
MnTBAP and intranasal administration of CuZnSOD-containing
polyketal microparticles reduced the lung injury and mortality
[12]. Mn-SOD knockout mice usually die within ten days after
birth, whereas transgenic mice overexpressing human CuZn-SOD
or Mn-SOD show increased tolerance to oxygen toxicity [26–28].
One clinical study revealed that subcutaneous injection of bovine
CuZn-SOD may be helpful in reducing bronchopulmonary
dysplasia in preterm infants [7]. To the best of our knowledge,
this study is the first report of the protective effects of aerosolized
hEC-SOD in hyperoxia.
Superoxide anion plays a key role in oxygen toxicity.
Superoxide can undergo SOD dismutation to H2O2, which is
comparatively stable, or react with nitric oxide (NO) to form
peroxynitrite (ONOO
2). Superoxide anions can even participate
in Fenton reactions to produce hydroxyl radicals (OH
2). The
relatively insufficiency of EC-SOD caused by overproduction of
superoxide or proteolysis of EC-SOD induced by hyperoxia [14]
has been shown to direct the reactions towards the formation of
ONOO
2 and OH
2, which are highly reactive products and
important mediators of hyperoxia-induced lung injury [29]. The
activities of glutathione peroxidase and catalase, which catalyze
H2O2 to H2O, have been shown to increase after continuous
exposure to hyperoxic conditions [30]. An exogenous EC-SOD
supplement like the aerosol therapy in this experiment could
prevent accumulation of superoxide anions and its associated
oxidants and increase oxygen tolerance in hyperoxia. Another
important protective effect of EC-SOD involves its ability to
inhibit inflammation [13,31]. ROS can induce fragmentation of
several components of ECM (collagen, hyaluronan, and syndecan-
1, a heparan sulfate proteoglycan) and then the following
chemotaxis of neutrophils and inflammation. One of the anti-
inflammatory mechanisms of EC-SOD is by the binding to the
components of ECM and preventing their degradation [32–34]. In
ischemia and peritonitis models, EC-SOD gene transfer reduces
inflammatory cell migration by reducing the expression of
adhesion molecules and proinflammatory cytokines [31].
The anti-inflammatory effect at the cell surface and the
chemical properties of EC-SOD may in part be why aerosol
therapy with EC-SOD is more effective than treatment with
CuZn-SOD in protection against oxygen toxicity. Superoxide
produced in the mitochondria or released extracellularly by
activated neutrophils is important for the pathogenesis of
hyperoxia-induced lung injury, while the role of cytoplasmic
superoxide in oxygen toxicity is limited [29]. The anti-oxidant
effect of EC-SOD occurs at the surface of alveolar and endothelial
cells. EC-SOD prevents the cells from absorbing free radicals,
even into the lung parenchyma. Such an ‘‘antioxidant screen’’
outside of alveolar cells could reduce the cell damage as much as
possible. EC-SOD protein has been shown to be very stable and
displays marked resistance to high temperature [9]; thus, it was
suitable for aerosol therapy.
The delivery of aerosol drugs to the respiratory tract has some
advantages, including rapid onset, smaller required doses, and a
local pulmonary effect with fewer systemic side effects; addition-
ally, it is painless and relatively convenient. In this study, we
proved the fact that EC-SOD can be aerosolized effectively
and then be absorbed into alveoli and lung parenchyma by
IHC staining. The significant higher survival rate of EC-SOD
Figure 3. Effects of aerosolized CuZn-SOD and rhEC-SOD on
survival after 72 h of hyperoxia. Phosphate-buffered saline (PBS)
inhalation was used as the hyperoxia-induced lung injury control group.
The three treatment groups were Albumin, SOD1 (CuZn-SOD), and
SOD3 (rhEC-SOD) (n=24 in each group). The albumin treated group
was added as a non-SOD inhalation control group.
doi:10.1371/journal.pone.0026870.g003
Figure 4. Effects of aerosolized CuZn-SOD and rhEC-SOD on
lung injury after 96 h of hyperoxia. A. Pulmonary edema
demonstrated by the wet/dry weight ratio of the lungs (n=6 in each
group). B. Total cell count in BAL fluid (n=6 in each group; * P,0.05;
** P,0.01).
doi:10.1371/journal.pone.0026870.g004
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SOD treatment groups revealed the protective effect against
oxygen toxicity of aerosolized EC-SOD. Total cell counts in BAL
fluid [35] and pathology of lung revealed that EC-SOD is more
effective than CuZn-SOD for reducing lung injury, but the same
effect could not be demonstrated by the wet/dry ratio of lung. The
aerosolized proteins deposited in lungs are equal in two treatment
groups may account for the insignificant difference of wet/dry
between EC-SOD and CuZn-SOD groups. The results imply that
aerosol therapy may be an effective route of administration of EC-
SOD for protection against oxygen toxicity when high oxygen
concentration is needed in critically ill patients.
The use of biomarkers for oxidative stress may provide early
detection and further evaluation of oxidative damage. Several
biomarkers of oxidized lipids, proteins and DNA have been found.
8-OHdG was recently demonstrated as a useful biomarker of
oxidative stress in various tissues [36] and even the marker in urine
is significantly correlated with the outcome of critically septic
patients [37]. When anti-oxidant systems are overwhelmed by
external oxidative stress, DNA can be damaged by ROS and then
strand breaks and modifications of various bases can occur. The 8-
OHdG adduct and its tautomer, 8-oxo-dG, can easily formed in
Figure 5. Effects of aerosolized CuZn-SOD and rhEC-SOD on lung morphology after 96 h of hyperoxia. Effects are shown as overview of
full lung organ (A), and histological lung section with H&E staining (B). The control group of mice fed in normal oxygen condition (Normoxia) was
shown in left panel. Following by inhalations of PBS, Albumin, SOD1 (CuZn-SOD), and SOD3 (rhEC-SOD) treated groups (n=6 in each group) under
the hyperoxia condition (FiO2.95%). The scale bars represent 500 mm.
doi:10.1371/journal.pone.0026870.g005
Figure 6. The distribution of aerosolized rhEC-SOD in lung
tissue by immunohistochemical (IHC) staining after 96 h of
hyperoxia. A. The image representative the PBS inhalation control
group. Only a few of endogenous EC-SOD can be detected in the
bronchial epithelia as indicated by open arrows. B. The image
representative the rhEC-SOD (SOD3) aerosolized group. The exogenous
rhEC-SOD can be strongly detected in the bronchial epithelia, alveoli
and lung parenchyma as indicated by solid black arrows. Scale
bar=100 mm.
doi:10.1371/journal.pone.0026870.g006
Figure 7. Effects of aerosolized CuZn-SOD and rhEC-SOD on
oxidative stress in lung and liver tissues after 72 h and 96 h of
hyperoxia. The levels of the oxidative stress biomarker 8-oxo-dG in
lung and liver tissues, measured with LC-MS/MS with on-line SPE, after
72 h (A) and 96 h (B) hyperoxia treatments. Values are expressed as the
amount of 8-oxo-dG per 10
6 dG (PBS was used as the control group;
n=6 in each group; * P,0.05; ** P,0.01).
doi:10.1371/journal.pone.0026870.g007
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instead of cytosine, which could cause GC-to-TA transversion and
lead to point mutations. The 8-OHdG adduct is cytotoxic by itself
because it can induce apoptosis through downregulation of bcl-2,
an antiapoptotic protein [38,39].
In this study, 8-oxo-dG in the lung tissue initially decreased
before it increased at day 3. A similar pattern was observed in liver
tissue, but there was a more dramatic elevation at day 3. The time
course of 8-oxo-dG in liver tissue was compatible with the
development of lung edema and the decline in the survival curve.
This trend implies that the antioxidant systems compensated well
at first, but prolonged oxygen exposure resulted in an elevation of
systemic oxidative stress. The levels of 8-oxo-dG were consistent
with the protective effect of the SODs. The initial decrease of 8-
oxo-dG could have been caused by increased activity of
antioxidants and/or activation of the DNA repair system or 8-
oxoquanine glycosylase 1 (OGG1). The later decompensation
could be the result of the proteolysis of antioxidant enzymes and/
or shutdown of the DNA repair systems. Further studies are
necessary to determine the mechanism.
Transgenesis using P. pastoris as a bioreactor to produce
functional protein therapeutic drugs is a promising direction in
biotechnology and medicine. Pichia pastoris is uniquely suited for
expressing transgenic proteins because of its ability to synthesize
large amounts of recombinant proteins. In addition, its glycosyl-
ation abilities are very similar to those of animal cells. The
recombinant proteins made by P. pastoris are unlikely to induce
immune reactions if they are injected into the bloodstream [40].
Aerosolized human CuZn-SOD in a sheep model and bovine
CuZn-SOD for preterm infants were found to be safe throughout
the course of treatment [7,41]. No side effects were found in this
aerosolized EC-SOD study, but this preparation will require
further investigations before clinical use.
In conclusion, we have successfully expressed human EC-SOD
in P. pastoris cells. Aerosolized recombinant hEC-SOD protected
against oxygen toxicity and reduced mortality in a mouse
hyperoxic model. The results of this study are encouraging, and
aerosol therapy with rhEC-SOD may permit patients with severe
hypoxemic respiratory failure, including ARDS, to receive high
levels of oxygen with less oxidative injury.
Supporting Information
Figure S1 The plot of oxygen levels in hyperoxia chambers
measured by oxygen analyzer (MiniOX I, MSA Canada, Inc.,
Canada) every hour during the housing of light cycle (6:00 am–
18:00 pm) for four days.
(JPG)
Video S1 The video of the health condition of mice behavior
observed during hyperoxia experiment. Mice that survived beyond
day 3 in the Albumin control group were clearly impaired and had
limited movement (right panel). In contrast, the mice in the rhEC-
SOD group demonstrated remarkable tolerance to hyperoxia (left
panel).
(MOV)
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